Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of intrapulmonary tetrahydrocannabinol administration in humans.
Zuurman L, Roy C, Schoemaker RC, Hazekamp A, den Hartigh J, Bender JC, Verpoorte R, Pinquier JL, Cohen AF, van Gerven JM. Zuurman L, et al. Among authors: van gerven jm. J Psychopharmacol. 2008 Sep;22(7):707-16. doi: 10.1177/0269881108089581. Epub 2008 May 30. J Psychopharmacol. 2008. PMID: 18515447 Clinical Trial.
Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
Strougo A, Zuurman L, Roy C, Pinquier JL, van Gerven JM, Cohen AF, Schoemaker RC. Strougo A, et al. Among authors: van gerven jm. J Psychopharmacol. 2008 Sep;22(7):717-26. doi: 10.1177/0269881108089870. Epub 2008 Jun 26. J Psychopharmacol. 2008. PMID: 18583433 Clinical Trial.
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.
Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS. Bossong MG, et al. Neuropsychopharmacology. 2009 Feb;34(3):759-66. doi: 10.1038/npp.2008.138. Epub 2008 Aug 27. Neuropsychopharmacology. 2009. PMID: 18754005 Clinical Trial.
Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effects.
Jacobs GE, Hulskotte EG, van Gerven JM, Zuurman L, de Kam ML, Elassaiss-Schaap J, Ruigt G, van Pelt J, Peeters BW, Peeters PA, Burggraaf J. Jacobs GE, et al. Among authors: van gerven jm, van pelt j. J Psychopharmacol. 2011 Mar;25(3):353-60. doi: 10.1177/0269881109358203. Epub 2010 Feb 8. J Psychopharmacol. 2011. PMID: 20142306 Clinical Trial.
218 results